Moxifloxacin Stulln Sine

Moxifloxacin, the active ingredient in Moxifloxacin Stulln Sine, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in adult patients. GNH USA supplies Moxifloxacin Stulln Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin Stulln Sine is a fluoroquinolone antibiotic used in ophthalmology to manage bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and speeds symptom resolution. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Post‑operative prophylaxis: prevents infection after ocular surgery such as cataract extraction.

Moxifloxacin Stulln Sine may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Foreign body sensation. - Tearing or increased lacrimation. - Blurred vision. - Mild headache.

Serious or Rare Side Effects: - Allergic reaction (e.g., swelling, rash, anaphylaxis). - Corneal ulceration or perforation. - Severe eye pain or photophobia. - Vision loss or sudden visual impairment. - Tendon rupture (systemic exposure). - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Moxifloxacin Stulln Sine, consider the following safety measures. - Allergy assessment: confirm no known hypersensitivity to fluoroquinolones. - Contraindication: avoid in patients with documented quinolone allergy. - Indication verification: use only for confirmed or strongly suspected bacterial eye infections. - Corneal monitoring: watch for signs of toxicity or delayed healing. - Contact lens use: advise patients to discontinue lenses during therapy. - Store at room temperature: keep in original container, protect from light and moisture.

Moxifloxacin Stulln Sine can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive risk of tendon rupture and QT prolongation. - Anticholinergic eye drops: may reduce drug penetration and efficacy.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: increased risk of secondary infection. - Non‑steroidal anti‑inflammatory eye drops: potential for delayed wound healing. - Herbal supplements such as ginkgo biloba: may enhance QT interval effects.